Accretion Pharmaceuticals IPO Subscription
The Accretion Pharmaceuticals IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Accretion Pharmaceuticals IPO has received bids for 2,00,06,400 shares against 25,87,300 shares offered, resulting in an overall subscription of 7.73x. the NII category is subscribed 4.41x, Retail Investors 10.55x, and QIBs 12.14x.
- Retail
- 10.55x
- NII
- 4.41x
- QIB
- 12.14x
- Total
- 7.73x
Current GMP
₹5 (+4.95%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Accretion Pharmaceuticals IPO Subscription Details ( Fri, 16 May 25 01:28 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 141,700 | 1,719,600 | 12.14x |
| Non-Institutional | 1,222,800 | 5,391,600 | 4.41x |
| Retail Investors | 1,222,800 | 12,895,200 | 10.55x |
| Total | 2,587,300 | 20,006,400 | 7.73x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 0 | - |
| Retail Investors | - | 0 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Accretion Pharmaceuticals IPO Live Subscription Status?
You can check the Accretion Pharmaceuticals IPO live subscription status on the IPO Master App or the official websites of the NSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Accretion Pharmaceuticals IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Accretion Pharmaceuticals IPO was subscribed 10.55 times as of Fri, May 16, 2025 06:58 PM. The public issue closed on Fri, May 16, 2025 for bidding.
How to subscribe Accretion Pharmaceuticals IPO?
Investors can apply for the Accretion Pharmaceuticals IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Accretion Pharmaceuticals IPO subscribed?
The Accretion Pharmaceuticals IPO was subscribed 7.73x times at the close of bidding period on Fri, May 16, 2025.
How to check Accretion Pharmaceuticals IPO allotment?
The Accretion Pharmaceuticals IPO allotment was finalized on Mon, May 19, 2025. You can check the Accretion Pharmaceuticals IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Accretion Pharmaceuticals IPO Be Listed?
The Accretion Pharmaceuticals IPO was listed on Wed, May 21, 2025, on the NSE.
What is the Accretion Pharmaceuticals IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Accretion Pharmaceuticals IPO was subscribed 12.14 times as of Fri, May 16, 2025 06:58 PM.